Tag Archives: PCL

Top 10 Clean Energy Stocks To Invest In 2019

Related CLNE 20 Biggest Mid-Day Losers For Friday Mid-Day Market Update: ConforMIS Gains Following Strong Q3 Results; MDC Partners Shares Drop Clean Energy Fuels Corp. – Bridge Funding For A Bridge Fuel (Seeking Alpha)
Related FRO Earnings Scheduled For November 29, 2016 Mid-Morning Market Update: Markets Mixed; Campbell Soup Profit Misses Estimates Frontline's (FRO) CEO Robert McLeod on Q3 2016 Results – Earnings Call Transcript (Seeking Alpha)

 

Toward the end of trading Wednesday, the Dow traded down 0.35 percent to 18,388.83 while the NASDAQ declined 0.25 percent to 5,209.89. The S&P also fell, dropping 0.36 percent to 2,168.24.

Leading and Lagging Sectors

Wednesday afternoon, non-cyclical consumer goods & services shares gained by 0.10 percent..

In trading on Wednesday, energy shares fell by 1.72 percent. Meanwhile, top losers in the sector included Clean Energy Fuels Corp (NASDAQ: CLNE), down 5 percent, and Frontline Ltd. (NYSE: FRO), down 7 percent.

Top 10 Clean Energy Stocks To Invest In 2019: Plum Creek Timber Company, Inc.(PCL)

Advisors’ Opinion:

  • [By Shane Hupp]

    Press coverage about Plum Creek Timber (NYSE:PCL) has trended positive on Tuesday, Accern Sentiment reports. Accern ranks the sentiment of press coverage by monitoring more than twenty million news and blog sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores closest to one being the most favorable. Plum Creek Timber earned a daily sentiment score of 0.37 on Accern’s scale. Accern also gave media stories about the industrial goods maker an impact score of 45.0964567289057 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the stock’s share price in the near term.

  • [By Joseph Griffin]

    Media stories about Plum Creek Timber (NYSE:PCL) have trended somewhat positive this week, Accern Sentiment reports. Accern identifies negative and positive news coverage by analyzing more than twenty million news and blog sources. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Plum Creek Timber earned a media sentiment score of 0.15 on Accern’s scale. Accern also gave news coverage about the industrial goods maker an impact score of 46.0048348022167 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the stock’s share price in the near future.

Top 10 Clean Energy Stocks To Invest In 2019: Allstate Corporation (ALL)

Advisors’ Opinion:

  • [By Logan Wallace]

    DF Dent & Co. Inc. lessened its stake in shares of Allstate Corp (NYSE:ALL) by 2.1% in the 2nd quarter, according to its most recent disclosure with the SEC. The firm owned 40,677 shares of the insurance provider’s stock after selling 868 shares during the period. DF Dent & Co. Inc.’s holdings in Allstate were worth $3,713,000 as of its most recent SEC filing.

  • [By Ethan Ryder]

    Zurich Insurance Group Ltd FI lessened its position in shares of Allstate Corp (NYSE:ALL) by 22.5% in the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 57,833 shares of the insurance provider’s stock after selling 16,753 shares during the period. Zurich Insurance Group Ltd FI’s holdings in Allstate were worth $5,278,000 at the end of the most recent quarter.

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Allstate (ALL)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Clean Energy Stocks To Invest In 2019: Proteon Therapeutics, Inc.(PRTO)

Advisors’ Opinion:

  • [By Max Byerly]

    Proteon Therapeutics (NASDAQ: PRTO) and Neurocrine Biosciences (NASDAQ:NBIX) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their earnings, profitability, risk, analyst recommendations, dividends, institutional ownership and valuation.

Top 10 Clean Energy Stocks To Invest In 2019: PACCAR Inc.(PCAR)

Advisors’ Opinion:

  • [By ]

    “Companies ranging from Action Alerts PLUS holding Microsoft (MSFT)  to heavy-truck maker Paccar (PCAR)  have over the years declared so-called ‘special dividends’ — one-time extra payments to shareholders. With the new U.S. tax law granting corporations a limited window to repatriate overseas profits at low tax rates, many companies might use the extra cash for special dividends. Let’s discuss how this impacts income investors,” writes Real Money Pro columnist Christopher Versace.

  • [By Ethan Ryder]

    KBC Group NV increased its position in shares of Paccar (NASDAQ:PCAR) by 9.2% in the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 92,983 shares of the company’s stock after purchasing an additional 7,832 shares during the quarter. KBC Group NV’s holdings in Paccar were worth $6,153,000 at the end of the most recent reporting period.

  • [By Max Byerly]

    State of New Jersey Common Pension Fund D bought a new position in shares of Paccar (NASDAQ:PCAR) in the 1st quarter, Holdings Channel reports. The fund bought 160,000 shares of the company’s stock, valued at approximately $10,587,000.

Top 10 Clean Energy Stocks To Invest In 2019: PRA Group, Inc.(PRAA)

Advisors’ Opinion:

  • [By Ethan Ryder]

    PRA Group (NASDAQ:PRAA) was upgraded by equities researchers at BidaskClub from a “sell” rating to a “hold” rating in a report released on Monday.

  • [By Logan Wallace]

    Carillon Tower Advisers Inc. raised its stake in PRA Group (NASDAQ:PRAA) by 706.8% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 84,032 shares of the business services provider’s stock after buying an additional 73,617 shares during the quarter. Carillon Tower Advisers Inc. owned about 0.19% of PRA Group worth $3,193,000 at the end of the most recent quarter.

  • [By Logan Wallace]

    Pra Group Inc (NASDAQ:PRAA) SVP Christopher D. Lagow sold 1,474 shares of the stock in a transaction on Thursday, September 13th. The stock was sold at an average price of $37.70, for a total value of $55,569.80. Following the transaction, the senior vice president now owns 18,273 shares of the company’s stock, valued at $688,892.10. The transaction was disclosed in a filing with the SEC, which is available at the SEC website.

  • [By Dan Caplinger]

    Collecting unpaid debts is a big business, and although there are many small players in the industry, some relatively large companies have sought to build scale in order to be as efficient as possible. PRA Group (NASDAQ:PRAA) has become a leader in debt collection, but what’s especially surprising is that even in a strong economy featuring low unemployment rates and steadily rising wage growth, the company has started to see some favorable trends in its collection activity.

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Pra Group (PRAA)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Clean Energy Stocks To Invest In 2019: Alder BioPharmaceuticals, Inc.(ALDR)

Advisors’ Opinion:

  • [By Max Byerly]

    Bioblast Pharma (NASDAQ: ALDR) and Alder Biopharmaceuticals (NASDAQ:ALDR) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their profitability, analyst recommendations, valuation, institutional ownership, risk, earnings and dividends.

  • [By Stephan Byrd]

    BidaskClub cut shares of Alder Biopharmaceuticals (NASDAQ:ALDR) from a strong-buy rating to a buy rating in a report released on Tuesday.

    A number of other equities research analysts have also weighed in on the company. Goldman Sachs Group initiated coverage on Alder Biopharmaceuticals in a research report on Tuesday, April 24th. They set a neutral rating and a $17.00 price objective on the stock. Mizuho restated a buy rating and set a $29.00 price objective on shares of Alder Biopharmaceuticals in a research report on Wednesday, March 28th. Cowen set a $23.00 price target on Alder Biopharmaceuticals and gave the company a buy rating in a research report on Monday, February 26th. Leerink Swann reiterated an outperform rating on shares of Alder Biopharmaceuticals in a research report on Sunday, March 4th. Finally, Zacks Investment Research lowered Alder Biopharmaceuticals from a hold rating to a sell rating in a research report on Tuesday, May 1st. One analyst has rated the stock with a sell rating, three have given a hold rating and eleven have issued a buy rating to the company. Alder Biopharmaceuticals currently has an average rating of Buy and a consensus target price of $26.33.

  • [By Ethan Ryder]

    Alder Biopharmaceuticals (NASDAQ:ALDR) was upgraded by BidaskClub from a “hold” rating to a “buy” rating in a research report issued on Monday.

  • [By Ethan Ryder]

    Needham & Company LLC assumed coverage on shares of Alder Biopharmaceuticals (NASDAQ:ALDR) in a report issued on Wednesday. The brokerage issued a buy rating and a $28.00 price objective on the biopharmaceutical company’s stock.

Top 10 Clean Energy Stocks To Invest In 2019: Cincinnati Financial Corporation(CINF)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Swiss National Bank lowered its holdings in Cincinnati Financial (NASDAQ:CINF) by 13.6% in the first quarter, HoldingsChannel reports. The firm owned 498,032 shares of the insurance provider’s stock after selling 78,400 shares during the quarter. Swiss National Bank’s holdings in Cincinnati Financial were worth $36,984,000 as of its most recent SEC filing.

  • [By Shane Hupp]

    Oppenheimer & Co. Inc. decreased its position in Cincinnati Financial Co. (NASDAQ:CINF) by 5.7% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 15,145 shares of the insurance provider’s stock after selling 914 shares during the quarter. Oppenheimer & Co. Inc.’s holdings in Cincinnati Financial were worth $1,013,000 at the end of the most recent quarter.

  • [By Stephan Byrd]

    BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp increased its position in Cincinnati Financial Co. (NASDAQ:CINF) by 6.4% in the 1st quarter, according to its most recent 13F filing with the SEC. The firm owned 58,582 shares of the insurance provider’s stock after buying an additional 3,527 shares during the period. BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp’s holdings in Cincinnati Financial were worth $4,350,000 at the end of the most recent quarter.

Top 10 Clean Energy Stocks To Invest In 2019: Keryx Biopharmaceuticals, Inc.(KERX)

Advisors’ Opinion:

  • [By Maxx Chatsko]

    Shares of Keryx Biopharmaceuticals (NASDAQ:KERX) dropped nearly 20% last month, according to data from S&P Global Market Intelligence. The pharma company announced second-quarter and first-half 2018 results that included disappointing sales revenue for its only drug, Auryxia. As a result, sales lagged behind consensus estimates despite delivering strong year-over-year growth.

  • [By Shane Hupp]

    ILLEGAL ACTIVITY WARNING: “Bank of New York Mellon Corp Sells 69,607 Shares of Keryx Biopharmaceuticals (KERX)” was originally published by Ticker Report and is owned by of Ticker Report. If you are accessing this piece of content on another publication, it was stolen and republished in violation of US and international copyright and trademark laws. The correct version of this piece of content can be read at https://www.tickerreport.com/banking-finance/4158332/bank-of-new-york-mellon-corp-sells-69607-shares-of-keryx-biopharmaceuticals-kerx.html.

  • [By Shane Hupp]

    Keryx Biopharmaceuticals (NASDAQ:KERX)‘s stock had its “buy” rating reaffirmed by equities researchers at HC Wainwright in a report issued on Thursday. They currently have a $9.00 price objective on the biopharmaceutical company’s stock. HC Wainwright’s price objective would indicate a potential upside of 174.39% from the stock’s current price.

  • [By Stephan Byrd]

    Shares of Keryx Biopharmaceuticals (NASDAQ:KERX) have received a consensus rating of “Hold” from the eight brokerages that are covering the firm, Marketbeat.com reports. Two analysts have rated the stock with a sell rating, five have given a hold rating and one has assigned a buy rating to the company. The average 12 month price objective among brokerages that have issued ratings on the stock in the last year is $6.00.

Top 10 Clean Energy Stocks To Invest In 2019: CBOE Holdings Inc.(CBOE)

Advisors’ Opinion:

  • [By Motley Fool Transcription]

    Cboe Global Markets, Inc. (NYSEMKT:CBOE)Q4 2018 Earnings Conference CallFeb. 8, 2019, 8:30 a.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Sean Williams]

    But times have changed, the virtual-currency market has matured a bit, and institutional investors have had a means to bet on the crypto market in a more traditional sense over the past couple of months. By this, I mean that both the CME Group and CBOE Global Markets (NASDAQ:CBOE) have offered bitcoin futures on their trading platforms since December, providing a more traditional avenue for Wall Street to place its bets.

  • [By Ethan Ryder]

    State of Tennessee Treasury Department lessened its stake in shares of Cboe Global Markets Inc (NASDAQ:CBOE) by 23.3% in the first quarter, Holdings Channel reports. The institutional investor owned 110,676 shares of the financial services provider’s stock after selling 33,675 shares during the quarter. State of Tennessee Treasury Department’s holdings in Cboe Global Markets were worth $12,628,000 as of its most recent filing with the SEC.

Top 10 Clean Energy Stocks To Invest In 2019: Oaktree Capital Group, LLC(OAK)

Advisors’ Opinion:

  • [By Motley Fool Staff]

    In this segment from MarketFoolery, host Chris Hill and Foolish investor-at-large Tim Hansen consider the annual letter released last week by billionaire investing guru Howard Marks of Oaktree Capital (NYSE:OAK). In it, he expressed concern about the number of questionable deals happening in this low interest rate environment, as an excess of optimism and high risk-tolerance send capital toward assets it should probably shun at current prices.

  • [By Benzinga News Desk]

    President Donald Trump hinted he may intervene in the Justice Department’s Russia investigation, as a Senate panel advanced a measure to protect Special Counsel Robert Mueller: Link

    ECONOMIC DATA
    USA GDP (QoQ) for Q1 2.30% vs 2.00% Est; Prior 2.90%
    The University of Michigan's consumer confidence index for April is schedule for release at 10:00 a.m. ET.
    The Baker Hughes North American rig count report for the latest week will be released at 1:00 p.m. ET.
    Data on farm prices for the recent week will be released at 3:00 p.m. ET.
    ANALYST RATINGS
    Stifel upgraded Facebook (NASDAQ: FB) from Hold to Buy
    Morgan Stanley upgraded Acacia Communications (NASDAQ: ACIA) from Underweight to Equal-Weight
    Jefferies downgraded Sunoco (NYSE: SUN) from Hold to Underperform
    KBW downgraded Oaktree Capital (NYSE: OAK) from Outperform to Market Perform

    This is a tool used by the Benzinga News Desk each trading day — it's a look at everything happening in the market, in five minutes. To get the full version of this note every morning, click here.

  • [By Daniel Miller, Jordan Wathen, and Jeremy Bowman]

    When it comes to dividend stocks, Coca-Cola Company (NYSE:KO) is a household name. In fact, the beverage giant just approved its 57th consecutive annual dividend increase, bumping it up to $0.40 per share and a juicy yield of 3.5%. But if investors are looking for even bigger dividend yields for their portfolios, three Motley Fool contributors suggest taking a peek at Macy’s (NYSE:M), Oaktree Capital Group (NYSE:OAK), and General Motors (NYSE:GM). Here’s why.

  • [By Motley Fool Staff]

    In this segment of Motley Fool Money, host Chris Hill asks senior analysts Jason Moser, Matt Argersinger, and Ron Gross to share which companies have been interesting them lately. Their responses run the investing gamut: alternative asset management firm Oaktree Capital (NYSE:OAK), sporting goods specialist Callaway Golf (NYSE:ELY), and media empire Disney (NYSE:DIS).

  • [By Logan Wallace]

    Oaktree Capital Group LLC (NYSE:OAK) Director Larry W. Keele sold 8,333 shares of the business’s stock in a transaction dated Thursday, August 9th. The shares were sold at an average price of $41.40, for a total transaction of $344,986.20. Following the completion of the transaction, the director now owns 8,656 shares in the company, valued at $358,358.40. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link.

  • [By Anders Bylund, Timothy Green, and Brian Feroldi]

    Read on to see why our panelists suggest picking up Applied Optoelectronics (NASDAQ:AAOI), Oaktree Capital (NYSE:OAK), and Q2 Holdings (NYSE:QTWO) right now.

Top High Tech Stocks To Invest In Right Now

For some time Airbus (OTCPK:EADSF) and Boeing (BA) have been talking about increasing production rates on their single aisle aircraft. The main reason – there was a need to stress their supply chains even more? They would point to this backlog. Both companies are sitting on record demand for their latest generation aircraft.

Click to enlarge

But these aircraft were ordered during the oil price spike. Oil prices may appear to be rising again. But don’t bet on prices staying higher for long. Oil producers are under economic stress. OPEC is an oligopoly. For the prices to stay high requires members of OPEC to stick to their quotas. Do you think Libya, Iran and Venezuela will stick to their quotas? To say nothing of Angola and Nigeria. We bet none of these nations will stick to their quotas. Their need for dollars outweighs all other deals. Cutting national incomes leads, almost certainly, to political unrest. Any price is worth avoiding that.

Top High Tech Stocks To Invest In Right Now: Plum Creek Timber Company, Inc.(PCL)

Advisors’ Opinion:

  • [By Shane Hupp]

    Press coverage about Plum Creek Timber (NYSE:PCL) has trended positive on Tuesday, Accern Sentiment reports. Accern ranks the sentiment of press coverage by monitoring more than twenty million news and blog sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores closest to one being the most favorable. Plum Creek Timber earned a daily sentiment score of 0.37 on Accern’s scale. Accern also gave media stories about the industrial goods maker an impact score of 45.0964567289057 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the stock’s share price in the near term.

Top High Tech Stocks To Invest In Right Now: Farmers National Banc Corp.(FMNB)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Farmers National Banc (NASDAQ:FMNB)‘s stock had its “hold” rating reissued by equities researchers at Keefe, Bruyette & Woods in a note issued to investors on Thursday. They presently have a $18.00 price target on the bank’s stock. Keefe, Bruyette & Woods’ price target would indicate a potential upside of 21.62% from the company’s previous close.

Top High Tech Stocks To Invest In Right Now: Trillium Therapeutics Inc.(TRIL)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Shares of Trillium Therapeutics Inc. (NASDAQ:TRIL) (TSE:TR) have been given an average rating of “Hold” by the six ratings firms that are covering the firm, Marketbeat Ratings reports. One investment analyst has rated the stock with a sell recommendation, two have given a hold recommendation and three have issued a buy recommendation on the company. The average 12 month target price among brokers that have issued a report on the stock in the last year is $10.94.

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Trillium Therapeutics (TRIL)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Hot Clean Energy Stocks To Invest In 2019

Clean energy stocks are still the best energy stocks to own right now, despite President Donald Trump pulling the United States out of the Paris Climate Accord. In fact, renewable energy production will see over 100% growth by 2025.

To help investors find the right renewable energy stocks, we’re giving Money Morning readers our top clean energy stock pick today…

Money Morning Global Energy Strategist Dr. Kent Moors says the United States might be pulling out of the climate agreement, but that won’t stop renewable energy from being crucial to meeting the global demand for energy.

Moors says the climate agreement was non-binding and voluntary, so the United States’ decision to leave it won’t change much. A more significant development is President Trump’s attempt to end the “Clean Power Plan,” an Obama-era initiative to promote clean energy, because it’s currently America’s policy instead of a non-binding agreement.

Hot Clean Energy Stocks To Invest In 2019: Genomic Health, Inc.(GHDX)

Advisors’ Opinion:

  • [By Max Byerly]

    Genomic Health (NASDAQ:GHDX) – Stock analysts at William Blair issued their Q1 2019 earnings estimates for Genomic Health in a research note issued to investors on Monday, June 4th. William Blair analyst A. Murphy forecasts that the medical research company will post earnings of $0.12 per share for the quarter. William Blair also issued estimates for Genomic Health’s Q2 2019 earnings at $0.16 EPS, Q3 2019 earnings at $0.20 EPS and Q4 2019 earnings at $0.21 EPS.

  • [By Logan Wallace]

    These are some of the news headlines that may have effected Accern Sentiment’s scoring:

    Get Genomic Health alerts:

    Zacks: Brokerages Expect Genomic Health, Inc. (GHDX) to Post $0.07 EPS (americanbankingnews.com) BioMarin Pharmaceutical (BMRN) Catches Eye: Stock Jumps 8.5% (finance.yahoo.com) Genomic Health (GHDX) vs. Veracyte (VCYT) Head-To-Head Contrast (americanbankingnews.com) PetMed (PETS) Optimistic About New Orders Amid Cost Woes (finance.yahoo.com) Genomic Health Inc. (GHDX) PT Raised to $56 at Canaccord Genuity (streetinsider.com)

    Genomic Health stock traded up $0.57 during mid-day trading on Wednesday, hitting $50.58. 868 shares of the company’s stock were exchanged, compared to its average volume of 337,252. The company has a market capitalization of $1.76 billion, a price-to-earnings ratio of 5,058.00 and a beta of 0.64. Genomic Health has a 1-year low of $26.54 and a 1-year high of $53.65.

  • [By Logan Wallace]

    Genomic Health (NASDAQ:GHDX) – Equities researchers at Piper Jaffray issued their Q2 2018 earnings per share (EPS) estimates for shares of Genomic Health in a research report issued on Wednesday, May 2nd. Piper Jaffray analyst W. Quirk expects that the medical research company will post earnings of $0.06 per share for the quarter. Piper Jaffray has a “Hold” rating and a $33.00 price target on the stock. Piper Jaffray also issued estimates for Genomic Health’s Q3 2018 earnings at $0.11 EPS, Q4 2018 earnings at $0.14 EPS, FY2018 earnings at $0.44 EPS, Q1 2019 earnings at $0.16 EPS, Q2 2019 earnings at $0.18 EPS, Q3 2019 earnings at $0.12 EPS, Q4 2019 earnings at $0.15 EPS and FY2019 earnings at $0.62 EPS.

Hot Clean Energy Stocks To Invest In 2019: Capricor Therapeutics, Inc.(CAPR)

Advisors’ Opinion:

  • [By Logan Wallace]

    Media headlines about Capricor Therapeutics (NASDAQ:CAPR) have trended somewhat positive this week, according to Accern Sentiment Analysis. Accern scores the sentiment of press coverage by analyzing more than twenty million blog and news sources in real time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Capricor Therapeutics earned a media sentiment score of 0.15 on Accern’s scale. Accern also assigned media stories about the biotechnology company an impact score of 46.8406921113539 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the stock’s share price in the near future.

Hot Clean Energy Stocks To Invest In 2019: United Natural Foods, Inc.(UNFI)

Advisors’ Opinion:

  • [By Steve Symington]

    As for individual stocks, fresh earnings news left shares of Five Below (NASDAQ:FIVE) and United Natural Foods (NASDAQ:UNFI) moving in opposite directions.

  • [By Ethan Ryder]

    United Natural Foods (NASDAQ:UNFI) had its price target lowered by Wells Fargo & Co from $50.00 to $45.00 in a research report report published on Thursday. The firm currently has a market perform rating on the stock.

  • [By Shane Hupp]

    United Natural Foods (NASDAQ:UNFI) had its price objective cut by Pivotal Research from $34.00 to $33.00 in a report released on Wednesday morning. They currently have a sell rating on the stock.

  • [By Joseph Griffin]

    United Natural Foods (NASDAQ:UNFI) updated its FY18 earnings guidance on Wednesday. The company provided earnings per share (EPS) guidance of $3.18-3.23 for the period, compared to the Thomson Reuters consensus estimate of $3.10. The company issued revenue guidance of $10.2-10.3 billion, compared to the consensus revenue estimate of $10.10 billion.

Hot Clean Energy Stocks To Invest In 2019: Plum Creek Timber Company, Inc.(PCL)

Advisors’ Opinion:

  • [By Shane Hupp]

    Press coverage about Plum Creek Timber (NYSE:PCL) has trended positive on Tuesday, Accern Sentiment reports. Accern ranks the sentiment of press coverage by monitoring more than twenty million news and blog sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores closest to one being the most favorable. Plum Creek Timber earned a daily sentiment score of 0.37 on Accern’s scale. Accern also gave media stories about the industrial goods maker an impact score of 45.0964567289057 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the stock’s share price in the near term.

Hot Clean Energy Stocks To Invest In 2019: First Business Financial Services Inc.(FBIZ)

Advisors’ Opinion:

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on First Business Financial Services (FBIZ)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com